## Background: Abnormalities of chromosome band 11q13 are frequent in squamous cell carcinoma of the head and neck (scchn). the oncogene ccnd1 is located at 11q13 and encodes cyclin d1, a cell cycle-regulating protein. the authors investigated the clinical relevance and associations between amplifi
The effect of cyclin D1 overexpression in human head and neck cancer cells
β Scribed by Torahiko Nakashima; Yuichiro Kuratomi; Ryuji Yasumatsu; Muneyuki Masuda; Koji Koike; Toshiro Umezaki; Gary L. Clayman; Takashi Nakagawa; Shizuo Komune
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 408 KB
- Volume
- 262
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The cyclin D1/CCND1 oncogene (PRAD1) is amplified in 15% of primary human breast cancers and overexpressed in 30-50% of breast cancers, suggesting that mechanisms in addition to DNA amplification may lead to deregulated expression of this gene in breast cancer. Cyclin D1 overexpression at a higher f
## Background: Overexpression of cyclin d1 has been documented in a number of human cancers. increased expression of cyclin d1 can contribute to cellular transformation and abnormal proliferation. ## Methods: Quantitative rt-pcr and/or western blot analysis were used to determine the level of cyc
The putative tumor suppressor gene p53 plays a key role in the regulation of cell proliferation. Functional loss of p53 protein through mutation or viral oncogene-complexing can result in p53 protein overexpression detectable by immunocytochemistry, which in turn has been associated with markers of
## Abstract ## Background. Nuclear/cytoplasmic accumulation of Ξ²βcatenin is mainly regulated by its degradation, which is initiated by interaction with adenomatous polyposis coli (APC) protein. Accumulation of Ξ²βcatenin activates the transcription of 1 of the target oncogenic genes, cyclin D1, in